These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 899936)

  • 21. Renal handling of calcium in hypoparathyroidism.
    Newman GH; Wade M; Hosking DJ
    Br Med J (Clin Res Ed); 1983 Sep; 287(6395):781-4. PubMed ID: 6412828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose tolerance and insulin secretion in patients with parathyroid disorders. Effect of serum calcium on insulin release.
    Yasuda K; Hurukawa Y; Okuyama M; Kikuchi M; Yoshinaga K
    N Engl J Med; 1975 Mar; 292(10):501-4. PubMed ID: 1117893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D and the syndromes of azotaemic osteodystrophy.
    Stanbury SW
    Contrib Nephrol; 1978; 13():132-46. PubMed ID: 361340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypoparathyroidism. Solved and unsolved pathologic physiological problems].
    Haas HG; Olah AJ; Dambacher M
    Dtsch Med Wochenschr; 1968 Jul; 93(29):1383-9. PubMed ID: 5658744
    [No Abstract]   [Full Text] [Related]  

  • 25. [Phosphate treatment in hypercalcemia].
    Kistler HJ; Neubauer W
    Klin Wochenschr; 1970 Jun; 48(12):741-52. PubMed ID: 5524894
    [No Abstract]   [Full Text] [Related]  

  • 26. Pediatric parathyroid disorders.
    Tsang RC; Noguchi A; Steichen JJ
    Pediatr Clin North Am; 1979 Feb; 26(1):223-49. PubMed ID: 379772
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acquired QT-syndrome with syncopes in hypoparathyroidism].
    Hartmann-Hornberger F; Rein R; Runge M
    Dtsch Med Wochenschr; 1988 Sep; 113(39):1515-9. PubMed ID: 3168776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
    Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
    J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vitamin D-related progressive renal insufficiency in an elderly patient with postsurgical hypoparathyroidism associated with extensive brain calcification].
    Fujiwara T
    Nihon Jinzo Gakkai Shi; 2012; 54(1):40-7. PubMed ID: 22413579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rate of disappearance of infused calcium in idiopathic and post-thyroidectomy hypoparathyroidism before and during vitamin D treatment.
    Mazzuoli GF; Antonozzi I; Coen G
    Calcif Tissue Res; 1968; ():Suppl:87-87a. PubMed ID: 5721102
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sevelamer hydrochloride and vitamin D for controlling serum calcium, phosphorus and bone metabolism in patients undergoing hemodialysis].
    Ishida M; Yao N; Yachiku S; Anzai T; Kobayashi T; Ishida H
    Clin Calcium; 2005 Sep; 15 Suppl 1():192-9. PubMed ID: 16279024
    [No Abstract]   [Full Text] [Related]  

  • 32. [A case of urolithiasis due to vitamin D intoxication in a patient with idiopathic hypoparathyroidism].
    Ichioka K; Moroi S; Yamamoto S; Kamoto T; Okuno H; Terai A; Terachi T; Ogawa O
    Hinyokika Kiyo; 2002 Apr; 48(4):231-4. PubMed ID: 12048937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of serum 25-hydroxyvitamin D measurements in hypoparathyroid and pseudohypoparathyroid patients treated with calciferol.
    Burns J; Paterson CR
    Clin Biochem; 1986 Feb; 19(1):49-51. PubMed ID: 3485479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D treatment of hypoparathyroid patients.
    Rizzoli R; Bonjour JP
    Eur J Endocrinol; 1997 Jan; 136(1):25-7. PubMed ID: 9037118
    [No Abstract]   [Full Text] [Related]  

  • 35. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
    Malluche HH; Ritz E
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
    [No Abstract]   [Full Text] [Related]  

  • 36. Total urinary hydroxyproline excretion after administration of Vitamin D to patients with hypoparathyroidism.
    Mautalen CA
    J Clin Endocrinol Metab; 1970 Nov; 31(5):595-9. PubMed ID: 4919045
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol.
    Pak CY; DeLuca HF; Chavez de los Rios JM; Suda T; Ruskin B; Delea CS
    Arch Intern Med; 1970 Aug; 126(2):239-47. PubMed ID: 4317441
    [No Abstract]   [Full Text] [Related]  

  • 38. A study of the renal excretion of calcium by the production of a constant level of hypercalcemia in normal and abnormal human subjects.
    Shaw WH
    Can J Physiol Pharmacol; 1971 May; 49(5):469-78. PubMed ID: 5120274
    [No Abstract]   [Full Text] [Related]  

  • 39. Is administration of vitamin D metabolite needed for the treatment of secondary hyperparathyroidism at the predialytic stage?
    Okada K; Takahashi S; Yanai M; Maejima M; Nagura Y; Hatano M
    Nephron; 1991; 58(4):492-3. PubMed ID: 1922623
    [No Abstract]   [Full Text] [Related]  

  • 40. Vitamin-D intoxication during treatment of hypoparathyroidism.
    Hossain M
    Lancet; 1970 May; 1(7657):1149-51. PubMed ID: 4192101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.